Dr. Gurwith joined Atom Bioscience in August of 2018 as our Chief Medical Officer. Previously, he was Executive Vice President, Scientific Affairs at PaxVax Inc. in 2017. From 2007 to 2017, Dr. Gurwith served as Chief Medical Officer at PaxVax. From 2001 to 2007, he was Senior Vice President, Medical Affairs, and Chief Medical Officer at VaxGen, Inc. From 1997 to 2001, Dr, Gurwith served as Vice President of Drug Development and Chief Medical Officer at Genelabs Technologies. Inc. In his previous career, Dr. Gurwith was an Associate Professor of Medicine at University of Kansas School of Medicine, UCLA, and Michigan State University. He was Vice President of Clinical Research at Sequus Pharmaceuticals. Dr. Gurwith obtained his M.D. from the Harvard University, Medical School and his B.A. from the Yale University. He did his Medical Resident at the Stanford University, School of Medicine. He also received his J.D. from the Temple University School of Law.